Sector overview← All sectors

Healthcare & Life Sciences

Clinical intelligence inside HIPAA, HITRUST, and 21 CFR Part 11 boundaries.

Overview

Steinn operates within hospital networks, payer environments, and pharmaceutical R&D environments without PHI leaving the environment. Models are trained and served on-premise or in customer-controlled environments. Every clinical recommendation carries a complete provenance trail suitable for FDA submission.

Capabilities

What we deliver.

04 MODULES
01

Clinical Decision Support

Real-time triage and protocol adherence with citation back to source guidelines.

02

Trial Operations

Site selection, cohort identification, and protocol-deviation detection across federated EHR data.

03

Pharmacovigilance

Adverse-event signal detection across narrative, structured, and post-market sources.

04

Payer Integrity

Prior-authorization automation and FWA detection with full audit substantiation.

Regulatory frameworks

Operates within.

HIPAAHITRUST CSF21 CFR Part 11GxPEU GDPR Art. 9
Client engagements

Representative work.

Client / 01

Academic medical center — sepsis surveillance

Continuous sepsis-risk inference across 14 hospitals. Time-to-antibiotic reduced by 47 minutes median. No PHI left the environment.

Client / 02

Top-10 pharma — pharmacovigilance

Unified adverse-event signal detection across 22 markets. Case-processing throughput up 4.6x. Full 21 CFR Part 11 audit trail.

Next step

Request a briefing.

Request Briefing →